
Loading, please wait...

Loading, please wait...

Ramaiah Memorial Hospital recently achieved a landmark by securing FACT accreditation India. Moreover, the Bengaluru-based facility now joins an elite group of global transplant centers. It is the only Indian hospital holding both FACT and Joint Commission International certifications. This dual recognition underscores the hospital's commitment to exceptional patient care and clinical safety.
Specialists regard FACT standards as the gold standard for hematopoietic stem cell transplantation. Consequently, these requirements ensure safety across the entire transplant ecosystem. The evaluation covers donor safety, clinical protocols, and long-term outcome reporting. Unlike general audits, this process focuses specifically on the complexities of cellular therapy. Therefore, this achievement marks a significant step forward for oncology and hematology standards in the country.
India currently faces a significant burden of hematologic disorders and blood cancers. Specifically, the country records over 120,000 new blood cancer cases every year. Additionally, many patients suffer from thalassemia, which requires bone marrow transplantation for a cure. Standardized programs are essential to improve the success rate of these procedures. Currently, the hospital evaluates nearly 1,000 patients with various blood disorders annually.
Academic mentorship from the University of Illinois helped the hospital align its protocols with international best practices. Furthermore, this partnership strengthens clinical confidence and standardizes treatment for complex cases. The accreditation also prepares the facility for advanced cellular therapies in the future. Thus, RMH continues to lead the way in improving healthcare quality within the region. This milestone ultimately benefits patients seeking curative treatments for severe blood diseases.
Q1: Why is FACT accreditation India significant for patients?
This accreditation ensures that a hospital follows the most rigorous global standards for safety and quality in cellular therapy. Consequently, it provides patients and donors with higher confidence in transplant outcomes and clinical protocols.
Q2: How does RMH distinguish itself from other transplant centers in India?
RMH is currently the only hospital in India to hold both FACT and JCI accreditations. This dual certification confirms that the facility meets international benchmarks for both general hospital infrastructure and specialized transplant care.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Ramaiah Memorial Hospital earns FACT accreditation for cellular therapy, becoming a leader in global quality standards for Indian bone marrow transplants....
6 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today